Patient profile of nonresponders to ustekinumab in moderate-to-severe psoriasis patients enrolled in the Corrona Psoriasis Registry

被引:0
|
作者
van Voorhees, Abby S. [1 ]
Karki, Chitra [2 ]
Mason, Marc A. [2 ]
Harrold, Leslie R. [2 ]
Guo, Ning [2 ]
Guana, Adriana [3 ]
Tian, Haijun [3 ]
Herrra, Vivian [3 ]
Strober, Bruce E. [4 ]
机构
[1] Eastern Virginia Med Sch, Norfolk, VA 23501 USA
[2] Corrona LLC, Waltham, MA USA
[3] Novartis Pharmaceut, E Hanover, NJ USA
[4] Univ Connecticut, Storrs, CT USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
6184
引用
收藏
页码:AB216 / AB216
页数:1
相关论文
共 50 条
  • [1] Characterization of insufficient responders to ustekinumab in patients with moderate-to-severe psoriasis in the US Corrona Psoriasis Registry
    Van Voorhees, Abby S.
    Mason, Marc A.
    Harrold, Leslie R.
    Guo, Ning
    Guana, Adriana
    Tian, Haijun
    Herrera, Vivian
    Strober, Bruce E.
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (08) : 907 - 915
  • [2] Characterization of nonresponders to interleukin-17 inhibitors in moderate to severe psoriasis patients enrolled in the Corrona Psoriasis Registry
    Wu, Jashin J.
    Lin, Tinchi
    Kearns, Donovan G.
    Chat, Vipawee S.
    Litman, Heather J.
    Dube, Blessing
    McLean, Robert R.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB124 - AB124
  • [3] Effectiveness of guselkumab among patients with moderate-to-severe plaque psoriasis in the Corrona Psoriasis Registry
    Armstrong, April W.
    Callis-Duffin, Kristina
    Fitzgerald, Timothy
    Teeple, Amanda
    Uy, Jonathan
    Olurinde, Mobolaji
    Rowland, Katelyn
    McLean, Robert R.
    Guo, Lin
    Shan, Ying
    Van Voorhees, Abby S.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB122 - AB122
  • [4] Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis
    Prieto-Perez, Rocio
    Llamas-Velasco, Mar
    Cabaleiro, Teresa
    Solano-Lopez, Guillermo
    Marquez, Beatriz
    Roman, Manuel
    Ochoa, Dolores
    Talegon, Maria
    Dauden, Esteban
    Abad-Santos, Francisco
    [J]. PHARMACOGENOMICS, 2017, 18 (02) : 157 - 164
  • [5] Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis
    Dauden, E.
    Prieto-Perez, R.
    Llamas-Velasco, M.
    Cabaleiro, T.
    Abad-Santos, F.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (09) : S188 - S188
  • [6] Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
    Griffiths, Christopher E. M.
    Strober, Bruce E.
    van de Kerkhof, Peter
    Ho, Vincent
    Fidelus-Gort, Roseanne
    Yeilding, Newman
    Guzzo, Cynthia
    Xia, Yichuan
    Zhou, Bei
    Li, Shu
    Dooley, Lisa T.
    Goldstein, Neil H.
    Menter, Alan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (02): : 118 - 128
  • [7] Characterization of non-responders to interleukin-17 inhibitors in moderate to severe psoriasis patients enrolled in the Corrona(R) Psoriasis Registry
    Wu, J. J.
    Kearns, D. G.
    Lin, T. -c.
    Chat, V. S.
    Litman, H. J.
    Dube, B.
    McLean, R. R.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (08) : E531 - E533
  • [8] Describing the clinical and patient-reported outcomes of patients with scalp psoriasis enrolled in the Corrona Psoriasis Registry
    Callis-Duffin, Kristina
    Karki, Chitra
    Mason, Marc A.
    Gordon, Kenneth
    Harrison, Ryan W.
    Guana, Adriana
    Gilloteau, Isabelle
    Herrra, Vivian
    Lebwohl, Mark
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB105 - AB105
  • [9] Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
    Papp, Kim A.
    Blauvelt, Andrew
    Bukhalo, Michael
    Gooderham, Melinda
    Krueger, James
    Lacour, Jean-Philippe
    Menter, Alan
    Philipp, Sandra
    Sofen, Howard
    Tyring, Stephen
    Berner, Beate R.
    Visvanathan, Sudha
    Pamulapati, Chandrasena
    Bennett, Nathan
    Flack, Mary
    Scholl, Paul
    Padula, Steven J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (16): : 1551 - 1560
  • [10] The cost-effectiveness of ustekinumab for moderate-to-severe psoriasis
    Rouse, Nicole C.
    Farhangian, Michael E.
    Wehausen, Brooke
    Feldman, Steven R.
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2015, 15 (06) : 877 - 884